SCHEMBL31135000

SCHEMBL31135000

Cn1cnc(-c2cc(N)nc(S(C)(=O)=O)n2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CYP2E1 P05181 1/20 0.36
▸ CYP2A6 P11509 1/20 0.36
▸ CYP2B6 P20813 1/20 0.36
▸ LMNA P02545 5/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ LRRK2 Q5S007 1/20 0.33
▸ BPTF Q12830 1/20 0.33
▸ KAT6A Q92794 1/20 0.32
▸ SDHB P21912 4/20 0.32
▸ RAB9A P51151 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ NPSR1 Q6W5P4 3/20 0.32
▸ KDM4E B2RXH2 3/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ S1PR4 O95977 2/20 0.32
▸ TP53 P04637 2/20 0.32
▸ HPGD P15428 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30505019 0.74 KDM5B (0.41) LOXL2BPTFMAPK1KDM5B
SCHEMBL5022939 0.73 CCR1 (0.44) LMNASMN1; SMN2BPTFSDHBRAB9A
SCHEMBL28269314 0.71 NPC1 (0.41) LMNASMN1; SMN2BPTFSDHBRAB9A
SCHEMBL5017672 0.69 BPTF (0.47) LMNASMN1; SMN2BPTFSDHBRAB9A
SCHEMBL10519534 0.68 NOS3 (0.50) LMNASMN1; SMN2BPTFSDHBRAB9A
SCHEMBL25435575 0.68 LOXL2 (0.36) LOXL2CYP2C9CYP2C19CYP2E1CYP2A6
SCHEMBL21020091 0.67 KDM4E (0.67) CYP2C9CYP2C19LMNASMN1; SMN2SDHB
SCHEMBL8597269 0.66 LMNA (0.42) LMNASMN1; SMN2BPTFSDHBRAB9A
SCHEMBL5017675 0.66 LMNA (0.50) CYP2C9CYP2C19CYP2E1CYP2A6CYP2B6
SCHEMBL20092109 0.66 SYK (0.48) LOXL2CYP2C9CYP2C19CYP2E1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118946560-A POLO-like kinase 4 (PLK 4) inhibitors, pharmaceutical compositions, methods for their preparation and uses 修复治疗公司 2024-11-12 — — CN disclosed
Send feedback